Regulated cell death: discovery, features and implications for neurodegenerative diseases

J Cui, S Zhao, Y Li, D Zhang, B Wang, J Xie… - Cell Communication and …, 2021 - Springer
Regulated cell death (RCD) is a ubiquitous process in living organisms that is essential for
tissue homeostasis or to restore biological balance under stress. Over the decades, various …

Neuron-astrocyte interactions in Parkinson's disease

I Miyazaki, M Asanuma - Cells, 2020 - mdpi.com
Parkinson's disease (PD) is the second most common neurodegenerative disease. PD
patients exhibit motor symptoms such as akinesia/bradykinesia, tremor, rigidity, and postural …

Increased pyroptosis activation in white matter microglia is associated with neuronal loss in ALS motor cortex

E Van Schoor, S Ospitalieri, S Moonen, SO Tomé… - Acta …, 2022 - Springer
Amyotrophic lateral sclerosis (ALS) is characterized by the degeneration of motor neurons in
the motor cortex, brainstem, and spinal cord. Although ALS is considered a motor neuron …

Resveratrol inhibits NLRP3 inflammasome-induced pyroptosis and miR-155 expression in microglia through Sirt1/AMPK pathway

KU Tufekci, BI Eltutan, KB Isci, S Genc - Neurotoxicity research, 2021 - Springer
Resveratrol is a natural polyphenolic compound with a wide range of biological activities
such as antioxidant, anti-carcinogenic, anti-obesity, anti-aging, anti-inflammatory …

Pramipexole inhibits astrocytic NLRP3 inflammasome activation via Drd3-dependent autophagy in a mouse model of Parkinson's disease

A Dong, Y Yang, S Jiang, X Yao, D Qi, C Mao… - Acta Pharmacologica …, 2023 - nature.com
Inflammation is one of the pathogenic processes in Parkinson's disease (PD). Dopamine
receptor agonist pramipexole (PPX) is extensively used for PD treatment in clinics. A number …

MCC950 in the treatment of NLRP3-mediated inflammatory diseases: Latest evidence and therapeutic outcomes

S Bakhshi, S Shamsi - International Immunopharmacology, 2022 - Elsevier
Evidence suggests that various innate immune system components are involved in
pathological inflammatory conditions. Among these components, the NLR family pyrin …

NLRP3 inflammasome-mediated neuroinflammation and related mitochondrial impairment in Parkinson's disease

QQ Han, W Le - Neuroscience Bulletin, 2023 - Springer
Parkinson's disease (PD) is a common neurodegenerative disorder caused by the loss of
dopamine neurons in the substantia nigra and the formation of Lewy bodies, which are …

Salidroside Ameliorates Depression by Suppressing NLRP3-Mediated Pyroptosis via P2X7/NF-κB/NLRP3 Signaling Pathway

Y Chai, Y Cai, Y Fu, Y Wang, Y Zhang… - Frontiers in …, 2022 - frontiersin.org
Depression is a common and serious mental disorder. Data on its pathogenesis remain
unclear and the options of drug treatments are limited. Here, we explored the role of …

Research progress of targeting NLRP3 inflammasome in peripheral nerve injury and pain

W Li, J Liang, S Li, L Wang, S Xu, S Jiang… - International …, 2022 - Elsevier
Nerve injury and nerve pain are common diseases caused by neuroinflammation.
Numerous studies have shown that the activation of NLRP3 (nod-like receptor family, pyrin …

NLRP3 inflammasomes: a potential target to improve mitochondrial biogenesis in parkinson's disease

M Khot, A Sood, KP Tryphena, S Khan… - European Journal of …, 2022 - Elsevier
Parkinson's disease (PD) is a common neurodegenerative condition for which no approved
treatment exists to prevent collective neuronal death. There is ample evidence that …